NCT06245018 2024-02-07A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid TumorNuwacell Biotechnologies Co., Ltd.Phase NA Not yet recruiting50 enrolled